Barely Significant
← all excerpts

Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the <i>Magel2</i>-null mouse model of Prader-Willi syndrome.

Mol Ther Methods Clin Dev · 2022 · PMC9573893 · PMID 36284766

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

not yet significantp = 0.060so close (0.05 < p ≤ 0.1)
AAV-BDNF gene therapy yielded a trending, but not yet significant (p = 0.060), reduction in immobility of Magel2 -null mice during this test ( Figure 4 I).

also in 316 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.